Aptamer Group Plc APTA

LSE · United Kingdom · Health Technology

GBp 0.3100-0.01 (-1.59%)

Market open· Oct 1, 2026, 2:19 PM UTC· GBp · Data may be delayed

Company news

Yahoo FinanceSep 22, 2026

Secure the Aptamer Market Advantage: Benchmark SomaLogic, Aptamer Group, Base Pair Biotechnologies and NeoVentures as Precision Diagnostics and Therapeutics Reshape Revenue Through the Forecast Period

Aptamers are gaining traction in precision therapies, diagnostics and biosensors, driven by SELEX advances, lower production costs, personalized medicine and targeted drug delivery.Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Aptamers - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Aptamers was estimated at US$199.9 Million in 2025 and is projected to reach US$715.6 Million by 2032, growing at a CAGR of 20.0% from 2025 to 2032. This co

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.

Prices may be delayed and are for informational purposes only - not investment advice.